ProPhase Labs (PRPH)
(Delayed Data from NSDQ)
$4.20 USD
-0.06 (-1.41%)
Updated Jun 27, 2024 11:06 AM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Brokerage Reports
ProPhase Labs, Inc. [PRPH]
Reports for Purchase
Showing records 41 - 50 ( 50 total )
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: Reports an Underwhelming Quarter; Lowering Price Target to $9.00 from $25.00
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: Post Conf. Call Thoughts - A Horse of a Different Color
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: We Have the Capital, We Have the Platform- Special Cash Dividend Declared, Driven by a Strong Quarter
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: My Hometown: Town of Oyster Bay Steps Up for Testing
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: I Had the Covid Vaccine; Do I Still Need a Test? Yes.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: COVID-19 Response Package Yes, It Does Support Testing; We See ProPhase as Poised to Benefit
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: Research Department
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: Testing, Testing & More Testing; All Systems Are Go
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: We Visited the New Facility - Primed & Ready to Process
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: ProPhase Labs, Inc.
Industry: Medical - Drugs
BUY: A Saliva Diagnostic for COVID-INITIATION REPORT
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J